热消融通过STAT3/c-Met分子通路诱导肝内结直肠癌小鼠模型一过性转移生长
研究在肝内转移小鼠模型中发现,射频消融正常肝脏后1-3天内可促进肝内转移灶植入和生长,表现为转移瘤数目、细胞增殖和瘤内新生血管增加;c-Met或STAT3抑制剂可消除该效应。
要点
- 射频消融正常肝脏后存在1-3天的时间窗,期间肝内转移瘤数目和生长增加。
- 该促转移效应与STAT3/c-Met通路相关,抑制c-Met或STAT3可消除效应。
- 动物模型提示消融后短期促转移现象可能通过药物干预中和。
关键影像表现/征象
- RFA后行肿瘤细胞注射组转移瘤数目较假手术组增加:CT26为103±45 vs 52±44(P=.009),MC38为87±51 vs 39±20(P=.007)。
- RFA后行肿瘤细胞注射组细胞增殖(两组均P<.001)和瘤内新生血管(两组均P<.001)较假手术组增加。
- RFA后1天和3天行肿瘤细胞注射组上述指标亦增加(P<.05),而RFA后7天注射组无差异(P>.05)。
- 辅助使用c-Met或STAT3抑制剂可将RFA后肝内转移参数降至基线水平(P<.03),与假手术组相当(P>.05)。
诊断标准与关键数值
- CT26模型转移瘤数目:RFA组103±45 vs 假手术组52±44,P=.009。
- MC38模型转移瘤数目:RFA组87±51 vs 假手术组39±20,P=.007。
- 细胞增殖和瘤内新生血管:RFA组较假手术组均P<.001。
- RFA后1天和3天注射组指标增加P<.05,7天注射组无差异P>.05。
- c-Met或STAT3抑制后转移参数降至基线P<.03,与假手术组比较P>.05。
临床应用与阅片要点
- 动物模型显示RFA后1-3天为促转移时间窗,此期间行肿瘤细胞注射可增加肝内转移。
- c-Met或STAT3抑制剂在模型中可中和RFA后的促转移效应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Systemic protumorigenic effects have been noted after radiofrequency ablation (RFA) of normal liver and have been linked to an interleukin 6/signal transducer and activator of transcription 3 (STAT3)/hepatocyte growth factor (HGF)/tyrosine-protein kinase Met (c-Met)/vascular endothelial growth factor (VEGF) cytokinetic pathway. Purpose To elucidate kinetics of RFA protumorigenic effects on intrahepatic metastatic implantation and growth and determine potential molecular targets for pharmacologic suppression of these effects. Materials and Methods An intrahepatic metastasis model was established by implanting CT26 and MC38 tumor cells into 216 7-8-week-old male Balb/C and C57BL6 mice, respectively, by means of splenic injection. Between June 2017 and March 2019, mice underwent tumor injection, followed 24 hours later by either standardized RFA (70°C ± 1, 5 minutes, 1-cm tip) or a sham procedure (needle placement without heating) (12 animals per arm, n = 48). Next, RFA or sham procedures were performed, followed by splenic tumor cell injection at 1 day, 3 days, or 7 days later (six animals per arm, n = 72). Finally, PHA-665752 and S3I-201 were used to block c-Met or STAT3, respectively, prior to either RFA or sham treatment (six animals per arm, n = 96). Livers were harvested at 14 days for CT26 and 21days for MC38 for tumor quantification. Ki-67 and CD34 immunohistochemistry measured proliferative indexes and microvascular density, respectively. Data were compared with analysis of variance and the two-tailed Student t test. Results RFA performed after tumor cell injection induced increased metastatic tumor number (103 ± 45 vs 52 ± 44 [CT26], P = .009 and 87 ± 51 vs 39 ± 20 [MC38], P = .007), cellular proliferation (P < .001 for both), and intratumoral neovascularization (P < .001 for both), compared with the sham procedure. Tumor cell injection performed 1 day and 3 days after RFA also increased these indexes (P < .05), while no difference was demonstrated for cell injection 7 days after RFA (P > .05). Adjuvant c-Met or STAT3 inhibition reduced intrahepatic metastatic parameters after RFA to baseline (P < .03), equivalent to the sham group (P > .05). Conclusion Radiofrequency ablation of normal liver promotes intrahepatic metastatic implantation and increased growth over a short-lived (1-3 days) temporal window in animal models. This phenomenon can be potentially neutralized with specific inhibition of pathways including hepatocyte growth factor/tyrosine-protein kinase Met and signal transducer and activator of transcription 3. © RSNA, 2019 Online supplemental material is available for this article. See also the editorial by Nikolic in this issue.
引用
- Liao H, Ahmed M, Markezana A, et al. Thermal Ablation Induces Transitory Metastatic Growth by Means of the STAT3/c-Met Molecular Pathway in an Intrahepatic Colorectal Cancer Mouse Model. Radiology. 2019. PMID: 31845846. doi:10.1148/radiol.2019191023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。